Asao T, Shukuya T, Uemura K, Kitadai R, et al. Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospectiv Lung Cancer 2024;194:107894.
PMID: 39029359